Abstract FDG‐PET/CT is the current state‐of‐the‐art imaging in lymphoma and plays a
central role in treatment decisions. At diagnosis, accurate staging is crucial for appropriate …

Background Hodgkin lymphoma (HL) is one of the most common haematological
malignancies in young adults and, with cure rates of 90%, has become curable for the …

Purpose We examined the utility of post-therapy surveillance imaging in a large,
prospectively enrolled cohort of patients with diffuse large B-cell lymphoma (DLBCL) from …

Relapsed or refractory Hodgkin lymphoma is a challenging problem for clinicians who treat
hematologic malignancies. The standard management of these patients should include the …

Precision medicine is evolving to include a variety of data to optimize patient care and
improve outcome. Multimodality imaging is paving the way toward this goal. PET/CT with 18 …

Summary Positron Emission Tomography (PET) is a functional imaging technique that,
combined with computerized tomography (PET‐CT), is increasingly used in lymphoma. Most …

Predictive value (PV) of surveillance fluorodeoxyglucose positron emission tomography
(FDG‐PET) in patients with diffuse large B‐cell lymphoma (DLBCL) treated with …

The management approach in Hodgkin's (HL) and high-grade non-Hodgkin's lymphomas
(NHL) has shifted towards reducing the toxicity and long-term adverse effects associated …

The use of sensitive and specific imaging techniques for accurate initial staging and
evaluation of response to therapy in patients with lymphoma is essential for their optimal …

Purpose Surveillance imaging of asymptomatic patients with diffuse large B-cell lymphoma
(DLBCL) in first remission remains controversial. A decision-analytic Markov model was …